The US FTC announces proposed changes to the Hart-Scott-Rodino pre-merger notification rules for pharmaceutical companies

PROPOSED CHANGES TO HSR RULES FOR PHARMACEUTICAL COMPANIES* Today the Federal Trade Commission (FTC) announced proposed changes to the Hart-Scott-Rodino (HSR) premerger notification rules that will impact the types of transactions for which pharmaceutical companies will be required to file HSR notifications with the Department of Justice and FTC. The proposed

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

Quotation

Carla A. R. Hine, Jon B. Dubrow, The US FTC announces proposed changes to the Hart-Scott-Rodino pre-merger notification rules for pharmaceutical companies, 20 August 2012, e-Competitions August 2012, Art. N° 93425

Visites 38

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues